Target intelligence / Profile preview

50S ribosomal protein L27 (bL27) (bL27)

Target
bL27
Molecular classification
Ribosomal protein, Bacterial 50S ribosomal subunit protein
01

Overview

50S ribosomal protein L27 (bL27) is an essential component of the large subunit of the bacterial ribosome, located at the peptidyl transferase center (PTC) (UniProt: P0A7L8). The N-terminal tail of bL27 reaches into the catalytic heart of the ribosome, where it facilitates the orientation of tRNA molecules and stabilizes the transition state during peptide bond formation (PubMed: 15131269). Due to its central location, bL27 is a key structural element of the binding site for various clinically important antibiotics, including macrolides, lincosamides, and pleuromutilins (PubMed: 25108352). These drugs typically bind to the 23S rRNA in the PTC or the nascent peptide exit tunnel, and the presence of bL27 is crucial for the overall architecture of these drug-binding pockets. Mutations in bL27 or its absence can significantly reduce the rate of protein synthesis and alter the susceptibility of bacteria to these antimicrobial agents. As a highly conserved protein in bacteria, it is a significant target for understanding the mechanisms of translation and the development of new antibiotics to combat multi-drug resistant pathogens (PubMed: 17113138).

Other names
Ribosomal protein L27rpmA50S ribosomal protein L27
02

Mechanism of action

Inhibition of bacterial protein synthesis by interfering with the peptidyl transferase center (PTC) or the nascent peptide exit tunnel (NPET).

03

Biological functions

Protein synthesisTranslationPeptide bond formationRibosome assembly
04

Disease associations

Bacterial infection
05

Safety considerations

Development of antimicrobial resistancePotential mitochondrial toxicity due to similarity with eukaryotic mitochondrial ribosomes
06

Interacting drugs

Erythromycin

4 more in the full profile.

07

Biomarkers

Minimum inhibitory concentration (MIC)Bacterial protein synthesis rate

Beyond the preview

Go deeper on 50S ribosomal protein L27 (bL27) (bL27).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 50S ribosomal protein L27 (bL27) (bL27).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call